Can Fisher & Paykel Healthcare justify Nvidia-level premium amid tariff noise

Can Fisher & Paykel Healthcare justify Nvidia-level premium amid tariff noise
Fisher & Paykel Healthcare's Lewis Gradon addressed shareholders at the company's AGM. (Image: Jacques Steenkamp)
Stock & Trade
Most markets have them - market darlings which are treated as all but sacrosanct investments, whose shares are placed on a pedestal and priced far above multiples of their competitors. Overowned and overbought, with fundamentals that are rarely subject to strict scrutiny.Does Fisher & Paykel Healthcare fall into this camp?Get up to date fast. Join BusinessDesk's WhatsApp channel.Its shares trade 58 times trailing earnings – nosebleed territory – which puts it at a significant premium to other blue-chip medical technolog...

More Markets

NZ stocks end flat as US Fed decision looms
Markets Market Close

NZ stocks end flat as US Fed decision looms

Market finishes slightly down as telco company Spark loses more ground.

Jamie Gray 12 Sep 2025
Locate Technologies plans to quit ASX for NZX
Markets

Locate Technologies plans to quit ASX for NZX

Bitcoin-favouring Locate Technologies eyes move to NZX's main board.

Staff reporters 12 Sep 2025
Vital takeover bid passes threshold at 11th hour
Markets

Vital takeover bid passes threshold at 11th hour

Tait International has secured acceptances to meet the 90% minimum condition for its Vital takeover less than a day before the offer was set to expire.Vital filed a substantial product holder (SPH) notice to the NZX on Friday morning, which showed Tait's stake lifted to 92.1%...

Gregor Thompson 12 Sep 2025
Tower again hikes FY underlying profit outlook
Markets

Tower again hikes FY underlying profit outlook

Insurer sees FY underling profit up as large events weigh less than expected     

Staff reporters 12 Sep 2025